EPISODE · May 23, 2022 · 18 MIN
Dr. Robert Kaufman and the new ValidCare Safety Study on CBD
from Hemp Legally Speaking · host Jonathan Miller - National Leading Hemp Attorney & Advocate
Hemp Industry Episode Resources:Host: Jonathan MillerGuest: Dr. Robert KaufmanBlog: Hemp Legally SpeakingHemp Industry questions covered in the episode:What does the ValidCare study demonstrate about the safety of ingestible CBD?What did the study conclude about CBD’s liver toxicity and how does this contrast with studies done on Epidiolex, the CBD drug used by children with rare forms of epilepsy?How does the study address concerns about drowsiness and low testosterone?Statistically speaking, how strong are the study’s conclusionsWhat’s the message that Dr. Kaufman will be sharing with FDA in its upcoming meeting?
Embed this episode
What this episode covers
Jonathan Miller interviews Dr. Robert Kaufman, the Director of research for ValidCare, a leading national independent research firm that recently completed a safety study on orally-ingested CBD. The study provides data that addresses FDA’s specific safety concerns regarding CBD, and has led to renewed industry calls urging FDA to regulate CBD now. If you have questions about the episode or ideas for hemp related topics, email us at [email protected].
Ready to play
Dr. Robert Kaufman and the new ValidCare Safety Study on CBD
No transcript for this episode yet
Similar Episodes
Dec 30, 2025 ·43m
Similar Podcasts
No similar podcasts found.